Tumor-penetrating therapy for β5 integrin-rich pancreas cancer

The iRGD tumor-penetrating peptide can achieve tumor specific drug delivery but whether and how it can penetrate into desmoplastic tumors is unknown. Here, the authors show that β5 integrin expression on tumor cells, mediated by CAFs-derived TGF-β, is required for iRGD penetration into the desmoplas...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tatiana Hurtado de Mendoza, Evangeline S. Mose, Gregory P. Botta, Gary B. Braun, Venkata R. Kotamraju, Randall P. French, Kodai Suzuki, Norio Miyamura, Tambet Teesalu, Erkki Ruoslahti, Andrew M. Lowy, Kazuki N. Sugahara
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/80f9f85745054067b544050e7b18b670
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:80f9f85745054067b544050e7b18b670
record_format	dspace
spelling	oai:doaj.org-article:80f9f85745054067b544050e7b18b6702021-12-02T13:34:55ZTumor-penetrating therapy for β5 integrin-rich pancreas cancer10.1038/s41467-021-21858-12041-1723https://doaj.org/article/80f9f85745054067b544050e7b18b6702021-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21858-1https://doaj.org/toc/2041-1723The iRGD tumor-penetrating peptide can achieve tumor specific drug delivery but whether and how it can penetrate into desmoplastic tumors is unknown. Here, the authors show that β5 integrin expression on tumor cells, mediated by CAFs-derived TGF-β, is required for iRGD penetration into the desmoplastic PDAC microenvironment and that iRGD-based combination therapy is effective in PDAC mouse models.Tatiana Hurtado de MendozaEvangeline S. MoseGregory P. BottaGary B. BraunVenkata R. KotamrajuRandall P. FrenchKodai SuzukiNorio MiyamuraTambet TeesaluErkki RuoslahtiAndrew M. LowyKazuki N. SugaharaNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Tatiana Hurtado de Mendoza Evangeline S. Mose Gregory P. Botta Gary B. Braun Venkata R. Kotamraju Randall P. French Kodai Suzuki Norio Miyamura Tambet Teesalu Erkki Ruoslahti Andrew M. Lowy Kazuki N. Sugahara Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
description	The iRGD tumor-penetrating peptide can achieve tumor specific drug delivery but whether and how it can penetrate into desmoplastic tumors is unknown. Here, the authors show that β5 integrin expression on tumor cells, mediated by CAFs-derived TGF-β, is required for iRGD penetration into the desmoplastic PDAC microenvironment and that iRGD-based combination therapy is effective in PDAC mouse models.
format	article
author	Tatiana Hurtado de Mendoza Evangeline S. Mose Gregory P. Botta Gary B. Braun Venkata R. Kotamraju Randall P. French Kodai Suzuki Norio Miyamura Tambet Teesalu Erkki Ruoslahti Andrew M. Lowy Kazuki N. Sugahara
author_facet	Tatiana Hurtado de Mendoza Evangeline S. Mose Gregory P. Botta Gary B. Braun Venkata R. Kotamraju Randall P. French Kodai Suzuki Norio Miyamura Tambet Teesalu Erkki Ruoslahti Andrew M. Lowy Kazuki N. Sugahara
author_sort	Tatiana Hurtado de Mendoza
title	Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
title_short	Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
title_full	Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
title_fullStr	Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
title_full_unstemmed	Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
title_sort	tumor-penetrating therapy for β5 integrin-rich pancreas cancer
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/80f9f85745054067b544050e7b18b670
work_keys_str_mv	AT tatianahurtadodemendoza tumorpenetratingtherapyforb5integrinrichpancreascancer AT evangelinesmose tumorpenetratingtherapyforb5integrinrichpancreascancer AT gregorypbotta tumorpenetratingtherapyforb5integrinrichpancreascancer AT garybbraun tumorpenetratingtherapyforb5integrinrichpancreascancer AT venkatarkotamraju tumorpenetratingtherapyforb5integrinrichpancreascancer AT randallpfrench tumorpenetratingtherapyforb5integrinrichpancreascancer AT kodaisuzuki tumorpenetratingtherapyforb5integrinrichpancreascancer AT noriomiyamura tumorpenetratingtherapyforb5integrinrichpancreascancer AT tambetteesalu tumorpenetratingtherapyforb5integrinrichpancreascancer AT erkkiruoslahti tumorpenetratingtherapyforb5integrinrichpancreascancer AT andrewmlowy tumorpenetratingtherapyforb5integrinrichpancreascancer AT kazukinsugahara tumorpenetratingtherapyforb5integrinrichpancreascancer
_version_	1718392746783277056

Tumor-penetrating therapy for β5 integrin-rich pancreas cancer

Ejemplares similares